Ligand Pharmaceuticals, Inc. (LGND)
207.74
-5.47
(-2.57%)
USD |
NASDAQ |
May 18, 16:00
208.09
+0.35
(+0.17%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (Quarterly) : 2.148M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.049M |
| Johnson & Johnson | 3.495B |
| Organon & Co. | 93.00M |
| Merck & Co., Inc. | 11.98B |
| Phathom Pharmaceuticals, Inc. | 7.771M |